FDA Drug Recalls

Recalls / Class II

Class IID-0326-2015

Product

Alprazolam tablets, USP, CIV, 0.25 mg, Rx Only, a) 500 count bottle, b) 1000 count bottle, Distributed by: Greenstone LLC, Peapack, NJ, 07977, a) NDC 59762-3719-3, b) NDC 59762-3719-4.

Brand name
Alprazolam
Generic name
Alprazolam
Active ingredient
Alprazolam
Route
Oral
NDCs
59762-3719, 59762-3720, 59762-3721, 59762-3722
FDA application
NDA018276
Affected lot / code info
Lot #: a) C100429, Exp 03/15, b) C120293, Exp 01/17

Why it was recalled

Subpotent Drug

Recalling firm

Firm
Neolpharma, Inc.
Manufacturer
Mylan Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
99 Calle Jardines, Caguas, Puerto Rico 00725-3382

Distribution

Quantity
12,310 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2014-12-17
FDA classified
2014-12-24
Posted by FDA
2014-12-31
Terminated
2017-04-26
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0326-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Alprazolam · FDA Drug Recalls